S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NASDAQ:EVER

EverQuote (EVER) Stock Price, News & Analysis

$18.39
+0.27 (+1.49%)
(As of 04/19/2024 ET)
Today's Range
$18.12
$18.97
50-Day Range
$14.75
$19.97
52-Week Range
$5.36
$20.74
Volume
286,186 shs
Average Volume
375,209 shs
Market Capitalization
$629.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.60

EverQuote MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
12.0% Upside
$20.60 Price Target
Short Interest
Healthy
3.45% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.23mentions of EverQuote in the last 14 days
Based on 19 Articles This Week
Insider Trading
Selling Shares
$7.66 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.43) to ($0.21) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.10 out of 5 stars

Finance Sector

648th out of 857 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

39th out of 58 stocks

EVER stock logo

About EverQuote Stock (NASDAQ:EVER)

EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

EVER Stock Price History

EVER Stock News Headlines

“More countries ditch the US dollar”
Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.
EverQuote (NASDAQ:EVER) Now Covered by B. Riley
“More countries ditch the US dollar”
Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.
EverQuote (NASDAQ:EVER) Shares Up 3.9%
EverQuote (NASDAQ:EVER) Reaches New 52-Week High at $20.74
EverQuote (NASDAQ:EVER) Trading Up 2.1%
Everquote CFO sells shares worth over $160k
EverQuote Inc CFO Joseph Sanborn Sells 8,051 Shares
Everquote CTO sells shares worth over $42,000
EverQuote Inc CEO Jayme Mendal Sells 5,750 Shares
See More Headlines
Receive EVER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EverQuote and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2024
Today
4/21/2024
Next Earnings (Confirmed)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:EVER
Fax
N/A
Employees
381
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.60
High Stock Price Target
$25.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+12.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-51,290,000.00
Pretax Margin
-17.61%

Debt

Sales & Book Value

Annual Sales
$287.92 million
Book Value
$2.37 per share

Miscellaneous

Free Float
21,065,000
Market Cap
$629.49 million
Optionable
Optionable
Beta
0.90
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives


EVER Stock Analysis - Frequently Asked Questions

Should I buy or sell EverQuote stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for EverQuote in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EVER shares.
View EVER analyst ratings
or view top-rated stocks.

What is EverQuote's stock price target for 2024?

5 brokers have issued twelve-month price targets for EverQuote's shares. Their EVER share price targets range from $13.00 to $25.00. On average, they anticipate the company's share price to reach $20.60 in the next twelve months. This suggests a possible upside of 12.0% from the stock's current price.
View analysts price targets for EVER
or view top-rated stocks among Wall Street analysts.

How have EVER shares performed in 2024?

EverQuote's stock was trading at $12.24 at the beginning of the year. Since then, EVER stock has increased by 50.2% and is now trading at $18.39.
View the best growth stocks for 2024 here
.

When is EverQuote's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our EVER earnings forecast
.

How can I listen to EverQuote's earnings call?

EverQuote will be holding an earnings conference call on Monday, May 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were EverQuote's earnings last quarter?

EverQuote, Inc. (NASDAQ:EVER) released its earnings results on Monday, February, 26th. The company reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.31) by $0.12. The firm had revenue of $55.71 million for the quarter, compared to analyst estimates of $49.89 million. EverQuote had a negative trailing twelve-month return on equity of 34.38% and a negative net margin of 17.81%.

What guidance has EverQuote issued on next quarter's earnings?

EverQuote updated its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $78.0 million-$82.0 million, compared to the consensus revenue estimate of $65.1 million.

What is Jayme Mendal's approval rating as EverQuote's CEO?

31 employees have rated EverQuote Chief Executive Officer Jayme Mendal on Glassdoor.com. Jayme Mendal has an approval rating of 80% among the company's employees. 42.0% of employees surveyed would recommend working at EverQuote to a friend.

When did EverQuote IPO?

EverQuote (EVER) raised $0 in an IPO on Thursday, June 28th 2018. The company issued 0 shares at a price of $0.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity, JMP Securities, Needham, Oppenheimer, Raymond James and William Blair were co-managers.

Who are EverQuote's major shareholders?

EverQuote's stock is owned by a number of retail and institutional investors. Top institutional investors include Counterpoint Mutual Funds LLC (0.11%). Insiders that own company stock include Craig Lister, Darryl Auguste, David B Blundin, David Brainard, David W Mason, Elyse Neumeier, George R Neble, Jayme Mendal, John Brandon Wagner, John L Shields, Jon Ayotte, Joseph Sanborn, Nicholas Graham, Paul F Deninger, Tomas Revesz Jr and Ventures Lllp Link.
View institutional ownership trends
.

How do I buy shares of EverQuote?

Shares of EVER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EVER) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners